Top Markets
#1 HOODIE HOODIE +2,907.18%
#2 Quai Network Quai Network +41.72%
#3 Threshold Network Threshold Network +40.73%
#4 Normie Normie +38.58%
#5 Keep Network Keep Network +37.00%
#6 Wecan Wecan +35.82%
#7 Yei Finance Yei Finance +25.79%
#8 Green Green +19.74%
#9 Lorenzo Protocol Lorenzo Protocol +17.43%
#10 Arrow Arrow +15.69%
Coin of the day
HOODIE HOODIE
Settings
Language
ENGLISH
Currency
USD
Theme
Median Technologies SA Median Technologies SA

Median Technologies SA

ALMDT
Rank in Stocks #11463
Median Technologies SA develops and markets software products and platforms for... Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device that integrates and optimizes the entire medical imaging workflow; and iSee for image analysis services in clinical trials. It also provides imaging contract research services, such as study start up, image and clinical data management, scientific consulting, independent reviews, image data processing and site support, and study close-out for studies. Median Technologies SA has a research collaboration agreement with the University of California. The company was founded in 2002 and is based in Valbonne, France.
Share Price
$5.49
Market Cap
$201.58M
Change (1 day)
0.43%
Change (1 year)
124.51%
Country
FR
Trade Median Technologies SA (ALMDT)

Category

Healthcare
Revenue for Median Technologies SA (ALMDT)
Revenue in Dec 2025 TTM: $27.41M
According to Median Technologies SA latest financial reports the company's current revenue (TTM) is $27.41M. In 2023 the company made a revenue of $24.57M a decrease compared to the revenue in the year 2022 that was $25.39M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Median Technologies SA from 2008 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $27.41M 14.77%
2024 $23.88M -2.81%
2023 $24.57M -3.23%
2022 $25.39M 8.67%
2021 $23.36M 42.34%
2020 $16.41M 63.44%
2019 $10.04M 37.85%
2018 $7.29M -21.00%
2017 $9.22M 37.95%
2016 $6.69M 58.49%
2015 $4.22M 6.23%
2014 $3.97M 140.09%
2013 $1.65M 41.51%
2012 $1.17M 21.75%
2011 $959.98K -37.30%
2010 $1.53M -7.26%
2009 $1.65M -18.31%
2008 $2.02M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $45.13B 164,584.33%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.27B 92,104.83%
US
Medtronic plc Medtronic plc
Medtronic plc
2M6.DE
 $36.37B 132,609.09%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $20.62B 75,119.73%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.30B 22,900.13%
US